Gastroenterology
Volume 138, Issue 7 , Pages 2348-2356, June 2010

Low Bone Mass and Severity of Cholestasis Affect Fracture Risk in Patients With Primary Biliary Cirrhosis

  • Núria Guañabens

      Affiliations

    • Metabolic Bone Diseases Unit, Service of Rheumatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
    • CIBERehd, Barcelona, Spain
    • Corresponding Author InformationReprint requests Address requests for reprints to: Núria Guañabens, Service of Rheumatology, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain
  • ,
  • Dacia Cerdá

      Affiliations

    • Metabolic Bone Diseases Unit, Service of Rheumatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
  • ,
  • Ana Monegal

      Affiliations

    • Metabolic Bone Diseases Unit, Service of Rheumatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
  • ,
  • Francesca Pons

      Affiliations

    • Metabolic Bone Diseases Unit, Service of Rheumatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
  • ,
  • Llorenç Caballería

      Affiliations

    • CIBERehd, Barcelona, Spain
    • Liver Unit, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
  • ,
  • Pilar Peris

      Affiliations

    • Metabolic Bone Diseases Unit, Service of Rheumatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
    • CIBERehd, Barcelona, Spain
  • ,
  • Albert Parés

      Affiliations

    • CIBERehd, Barcelona, Spain
    • Liver Unit, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain

Received 16 November 2009; accepted 9 February 2010. published online 22 February 2010.

Background & Aims

The influence of osteoporosis and liver disease on fracture risk is not well characterized in patients with primary biliary cirrhosis (PBC). We studied a large series of women with PBC to assess the prevalence and risk factors for fractures and the fracture threshold.

Methods

In female patients with PBC (n = 185; age, 55.7 ± 0.7 years; range 28–79 years), age, duration of PBC, menopausal status, and histologic stage and severity of liver disease were assessed. Vertebral and non-vertebral fractures were recorded in 170 and 172 patients, respectively. Osteoporosis and osteopenia were diagnosed based on densitometry analysis.

Results

The prevalences of vertebral, non-vertebral, and overall fractures were 11.2%, 12.2%, 20.8%, respectively. Osteoporosis was significantly more frequent in patients with PBC than in normal women. Osteoporosis was associated with age, weight, height, histologic stage, severity, and duration of liver damage; fractures were associated with osteoporosis, menopause, age, and height but not with severity of PBC. Osteoporosis was a risk factor for vertebral fracture (odds ratio [OR], 8.48; 95% confidence interval [CI]: 2.67–26.95). Lumbar T score <–1.5 (OR, 8.27; 95% CI: 1.84–37.08) and femoral neck T score <–1.5 (OR, 6.83; 95% CI: 1.48–31.63) were significant risk factors for vertebral fractures.

Conclusions

Fractures, particularly vertebral fractures, are associated with osteoporosis, osteopenia, and T scores less than –1.5, whereas osteoporosis and osteopenia are associated with the severity of liver damage. Patients with T scores less than –1.5 might require additional monitoring and be considered for therapy to prevent fractures.

Keywords: Metabolic Bone Disease, Bone Mineral Density, Osteoporosis, Osteopenia

Abbreviations used in this paper: PBC, primary biliary cirrhosis, BMD, bone mineral density

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported, in part, by Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, and FIS-08/0105, Ministerio de Ciencia e Innovación, Spain.

PII: S0016-5085(10)00207-6

doi:10.1053/j.gastro.2010.02.016

Gastroenterology
Volume 138, Issue 7 , Pages 2348-2356, June 2010